๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Behavioral effects and dopamine antagonist properties of N-alkylaminobenzazepines

โœ Scribed by J.B. Acri; J.H. Shah; A.H. Newman; Y.P. Belov; A.S. Basile; L.G. Sharpe; J.M. Witkin


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
815 KB
Volume
37
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

โœฆ Synopsis


Blockade of dopamine D, receptors has been suggested as a novel therapeutic approach to psychotic disorders and to psychomotor stimulant dependencies. Peripheral D, receptors have also been implicated in the acute lethal effects of cocaine. Attempts to synthesize a D, antagonist that does not penetrate the central nervous system led to the discovery of novel series of N-alkylammobenzazepine D, antagonists. In the present study, the most potent compound of that series, JHS 271, suppressed locomotor activity, and blocked cocaine-stimulated activity, apornorphine-induced stereotypies, and the lethal effects of cocaine in mice. Structural analogs of JHS 271 were also evaluated in selected assays. Potencies in these tests demonstrated a significant positive correlation with affinities for the D, receptor. These results implicate D, receptor blockade as a mechanism of action for JHS 271 and related compounds. Comparative studies of central vs. systemic administration and determination of blood/brain concentrations indicdted that JHS 271, like SCH 23390, can readily access central sites upon systemic application. o


๐Ÿ“œ SIMILAR VOLUMES


Dopamine and mania: Behavioral and bioch
โœ Robert M. Post; David C. Jimerson; William E. Bunney; Frederick K. Goodwin ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› Springer ๐ŸŒ English โš– 890 KB

Although recent data suggest that pimozide has effects at other neurotransmitter receptor sites, it is one of the more specific neuroleptics in its effects on dopamine receptors. We report that in manic patients pimozide produces substantial clinical improvement with a magnitude and time course simi

Repeated quinpirole treatment: Locomotor
โœ Dr. James K. Rowlett; Dr. Bruce A. Mattingly; Michael T. Bardo ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 942 KB

Repeated treatment with the non-selective dopamine agonist apomorphine results in behavioral sensitization and enhanced dopamine synthesis in dopamine projection fields. To examine the role of D2-type dopamine receptors in modulating these effects, the present experiment assessed the effects of repe